Yet another Acceleron investor challenges Merck’s $11.5B acquisition offer: Bloomberg
Yet another Acceleron investor challenges Merck’s $11.5B acquisition offer: Bloomberg [...]
After a phase of slower growth, Novo Nordisk sees the fruits of its Wegovy and Rybelsus launches, CEO says
After a phase of slower growth, Novo Nordisk sees the [...]
By unanimous vote, CDC advisory committee endorses Pfizer COVID-19 vaccine for kids 5-11
By unanimous vote, CDC advisory committee endorses Pfizer COVID-19 vaccine [...]
Novartis teams with advocacy group to bring visibility to atherosclerotic cardiovascular disease
Novartis teams with advocacy group to bring visibility to atherosclerotic [...]
Stallergenes, seeking an edge in a competitive space, taps Aptar for connected drug delivery project
Stallergenes, seeking an edge in a competitive space, taps Aptar [...]
AbbVie’s Parkinson’s pump hits goal in phase 3, setting stage for approval filings
AbbVie’s Parkinson’s pump hits goal in phase 3, setting stage [...]
Pfizer’s COVID vaccine for younger kids meets FDA bar, with CDC panel next week being key to wide rollout
Pfizer’s COVID vaccine for younger kids meets FDA bar, with [...]
Seagen stands by newly acquired HER2 breast cancer drug despite competition from AstraZeneca-Daiichi’s Enhertu
Seagen stands by newly acquired HER2 breast cancer drug despite [...]
Even AbbVie CEO can’t confirm Rinvoq’s sales as FDA mulls JAK label
Even AbbVie CEO can’t confirm Rinvoq’s sales as FDA mulls [...]
AbbVie’s Vraylar turns in mixed results in depression, but pharma decides to file for approval anyway
AbbVie’s Vraylar turns in mixed results in depression, but pharma [...]